Research
Mixed
High adherence to the Mediterranean diet does not significantly reduce the risk of prostate, pancreatic, esophageal, or blood cancers.
Do not rely on the Mediterranean diet to prevent prostate, pancreatic, esophageal, or blood cancers. While it offers protection against other cancers and mortality, these specific cancers may require different prevention strategies or screening protocols.
ModerateRefutesLOW confidence
Adhering to MedDiet did not modify risk of blood, esophageal, pancreatic and prostate cancer risk.
Why this rating
Based on observational studies with varying certainty, but consistent finding of no association.
Source
An updated systematic review and meta-analysis on adherence to mediterranean diet and risk of cancer
Jakub Morze et al. · European Journal of Nutrition · 2020
DOI 10.1007/s00394-020-02346-6
Meta-analysis · 117 studiesCited 352×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
Related findings · Mixed
- Bariatric surgery (VSG and RYGB) is the most effective and sustainable treatment for obesity, producing marked and sustained weight loss that non-surgical interventions cannot match.Strong
- Severely protein-deficient diets (2–3% energy) induce lean body mass loss and metabolic imbalance, whereas adequate protein intake (0.66 g/kg/d minimum) is a prerequisite for maintaining muscle, bone, and physiological function.Strong
- For patients with Class III obesity (BMI >39.9 kg/m2), metabolic bariatric surgery (MBS) is significantly more effective than any currently approved medication, with BilioPancreatic Diversion (BPD) showing the highest estimated weight loss.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →